Data for (Study ST003954)

(Analysis AN006500)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20F21F22F23F24F25F26F27F28F29F30F31F32F33F34F35F36F37F38F39F40F41F42F43F44F45F46F47F48F49F50F51F52F53F54F55F56F57F58F59F60F61F62
1,3-Dimethyluric-Acid 1.5165 NA 4.1319 NA 0.4597 0.0530 4.1337 0.1218 NA NA NA NA 0.0468 NA 2.6504 NA 0.8570 NA 0.3852 NA 0.7539 NA 0.0311 0.1170 0.7626 2.8012 NA NA 0.0853 NA 0.9499 3.3828 0.4990 NA 0.1671 NA 0.3579 0.0004 1.2133 0.1861 0.4709 NA 0.5570 0.5904 NA 2.2042 NA 1.8655 0.1062 0.6451 0.0338 NA 1.1293 NA NA NA 0.2054 0.1005 0.0012 1.1307 0.7856 0.4120
2-Aminoethanesulfonic-Acid 0.8628 0.7145 1.0649 0.8612 1.7650 0.8193 1.0069 1.0918 0.8600 0.9854 0.9322 0.8386 1.3576 1.1304 1.0267 0.7510 0.8479 1.1966 1.3996 1.1245 1.2366 0.4598 0.8381 1.0892 1.1189 0.9899 0.7560 1.0660 0.8986 1.3383 1.0914 0.8213 0.7775 1.1773 0.8193 1.1348 1.0598 0.9584 1.2220 1.1344 0.7092 0.7301 0.8189 1.5039 1.0270 1.1844 1.1824 1.1270 1.3804 0.8892 1.0321 1.1104 0.8584 1.1669 0.7734 0.7569 1.2235 1.1281 1.1206 0.8736 1.2161 0.7979
3,7-Dimethyluric-Acid NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
5-Hydroxy-tryptophan NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1.0000 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
argininosuccinic-acid 1.2051 1.0668 0.9728 1.3162 1.0040 0.8899 0.9050 1.0795 NA 1.1756 0.9955 0.7035 0.9342 1.0302 0.7757 0.9078 1.5478 0.8666 NA NA 0.7934 NA 0.8910 0.8161 1.0068 0.8476 0.7603 NA 1.2558 0.9088 0.8135 0.8021 0.9046 0.8257 0.8914 0.9233 0.9907 1.6258 NA 1.5341 0.9071 NA NA 1.0863 0.8430 NA NA 1.0394 0.6369 0.9850 1.0573 0.7897 0.9528 0.7960 0.8446 0.7247 1.1764 0.9381 1.0036 0.6814 1.0312 0.8989
L-Cystine 1.0698 0.8741 1.1592 1.4039 1.1646 1.1743 1.1023 1.3094 0.9307 0.8446 1.4938 1.0591 0.9689 0.7204 0.8030 0.7549 1.4915 0.8073 0.9504 0.8170 0.8886 0.7479 1.0041 0.8411 0.9923 1.2143 0.7660 0.8294 1.2970 1.2415 0.9377 1.2300 1.0311 1.4148 0.9328 0.8217 0.9541 1.4499 0.8213 1.1305 0.9562 0.5854 0.8578 0.7762 0.7243 0.8168 0.8285 0.8828 0.8423 0.8448 1.0745 1.0033 1.4135 0.6233 1.2409 0.6620 0.9277 1.1528 0.8947 0.6979 0.9655 1.1548
N-Isovaleroylglycine 0.0662 3.1078 NA 2.3261 NA NA 0.3785 NA 0.4984 0.6762 0.7963 NA NA 1.5830 NA NA NA NA NA 1.7165 2.3163 2.1498 NA NA 0.3606 0.7502 0.2164 0.8891 1.6954 NA NA NA 0.2796 NA NA NA 1.1731 NA 0.3146 NA NA NA 0.2675 NA 1.1461 NA 1.8163 2.1621 0.0977 1.1065 NA NA NA NA NA NA NA NA 0.9645 NA 0.0301 0.0487
N-Propionylglycine 0.7362 1.1799 0.4055 0.8781 1.4487 1.1989 0.4687 NA 1.4297 1.3457 1.3419 NA 0.8001 1.0418 NA NA 0.9854 1.2162 0.6431 1.1116 1.8450 2.3725 NA 0.8555 1.1543 1.3502 1.1872 0.7038 1.6058 1.0656 0.5103 0.7321 1.1411 0.4676 0.5222 0.4808 1.8279 NA 0.9834 0.6235 0.6234 1.2578 1.0904 0.8049 1.9964 0.7014 1.2172 1.7773 0.6572 0.9177 0.7931 NA 0.4416 0.6631 NA 0.7912 0.7751 0.6504 1.9233 0.4746 1.1303 0.9722
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Sample source:serum | Group1:HC | Group2:1
F2Sample source:serum | Group1:IBS-C-10 | Group2:1
F3Sample source:serum | Group1:IBS-C-11 | Group2:1
F4Sample source:serum | Group1:IBS-C-12 | Group2:1
F5Sample source:serum | Group1:IBS-C-13 | Group2:1
F6Sample source:serum | Group1:IBS-C-14 | Group2:1
F7Sample source:serum | Group1:IBS-C-15 | Group2:1
F8Sample source:serum | Group1:IBS-C-16 | Group2:1
F9Sample source:serum | Group1:IBS-C-1 | Group2:1
F10Sample source:serum | Group1:IBS-C-2 | Group2:1
F11Sample source:serum | Group1:IBS-C-3 | Group2:1
F12Sample source:serum | Group1:IBS-C-4 | Group2:1
F13Sample source:serum | Group1:IBS-C-5 | Group2:1
F14Sample source:serum | Group1:IBS-C-6 | Group2:1
F15Sample source:serum | Group1:IBS-C-7 | Group2:1
F16Sample source:serum | Group1:IBS-C-8 | Group2:1
F17Sample source:serum | Group1:IBS-C-9 | Group2:1
F18Sample source:serum | Group1:IBS-D-10 | Group2:1
F19Sample source:serum | Group1:IBS-D-11 | Group2:1
F20Sample source:serum | Group1:IBS-D-12 | Group2:1
F21Sample source:serum | Group1:IBS-D-13 | Group2:1
F22Sample source:serum | Group1:IBS-D-14 | Group2:1
F23Sample source:serum | Group1:IBS-D-15 | Group2:1
F24Sample source:serum | Group1:IBS-D-16 | Group2:1
F25Sample source:serum | Group1:IBS-D-17 | Group2:1
F26Sample source:serum | Group1:IBS-D-18 | Group2:1
F27Sample source:serum | Group1:IBS-D-19 | Group2:1
F28Sample source:serum | Group1:IBS-D-1 | Group2:1
F29Sample source:serum | Group1:IBS-D-20 | Group2:1
F30Sample source:serum | Group1:IBS-D-21 | Group2:1
F31Sample source:serum | Group1:IBS-D-22 | Group2:1
F32Sample source:serum | Group1:IBS-D-23 | Group2:1
F33Sample source:serum | Group1:IBS-D-24 | Group2:1
F34Sample source:serum | Group1:IBS-D-25 | Group2:1
F35Sample source:serum | Group1:IBS-D-26 | Group2:1
F36Sample source:serum | Group1:IBS-D-27 | Group2:1
F37Sample source:serum | Group1:IBS-D-28 | Group2:1
F38Sample source:serum | Group1:IBS-D-29 | Group2:1
F39Sample source:serum | Group1:IBS-D-2 | Group2:1
F40Sample source:serum | Group1:IBS-D-30 | Group2:1
F41Sample source:serum | Group1:IBS-D-31 | Group2:1
F42Sample source:serum | Group1:IBS-D-3 | Group2:1
F43Sample source:serum | Group1:IBS-D-4 | Group2:1
F44Sample source:serum | Group1:IBS-D-5 | Group2:1
F45Sample source:serum | Group1:IBS-D-6 | Group2:1
F46Sample source:serum | Group1:IBS-D-7 | Group2:1
F47Sample source:serum | Group1:IBS-D-8 | Group2:1
F48Sample source:serum | Group1:IBS-D-9 | Group2:1
F49Sample source:serum | Group1:IBS-M-10 | Group2:1
F50Sample source:serum | Group1:IBS-M-11 | Group2:1
F51Sample source:serum | Group1:IBS-M-12 | Group2:1
F52Sample source:serum | Group1:IBS-M-13 | Group2:1
F53Sample source:serum | Group1:IBS-M-14 | Group2:1
F54Sample source:serum | Group1:IBS-M-1 | Group2:1
F55Sample source:serum | Group1:IBS-M-2 | Group2:1
F56Sample source:serum | Group1:IBS-M-3 | Group2:1
F57Sample source:serum | Group1:IBS-M-4 | Group2:1
F58Sample source:serum | Group1:IBS-M-5 | Group2:1
F59Sample source:serum | Group1:IBS-M-6 | Group2:1
F60Sample source:serum | Group1:IBS-M-7 | Group2:1
F61Sample source:serum | Group1:IBS-M-8 | Group2:1
F62Sample source:serum | Group1:IBS-M-9 | Group2:1
  logo